Delivery Order SPE2DR25D2014-SPE2DR26FA2Q2
- Not listed
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Ibuprofen 800 mg tablets in quantities of 500 units. This firm fixed-price delivery order, valued at $5,354.10, is due for completion by July 21, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving critical federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 500 tablets of Ibuprofen 400 mg, with a ceiling value of $1,066.72. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by December 19, 2025. The award was issued on December 18, 2025, with performance to occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a small-value transaction...
- The Defense Logistics Agency awarded a delivery order valued at $1,521.26 to AmerisourceBergen Drug Corp for the supply of Ibuprofen 800 mg tablets (100 count) on January 8, 2026, with a completion date of January 9, 2026. This competitively awarded, firm fixed-price delivery order is being performed at the contractor's location in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was competed on a full and open basis among qualified pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 16, 2025, for the supply of Ibuprofen 800 mg tablets in quantities of 500 units under a firm fixed-price contract valued at $2,958.36. This non-set-aside delivery order is set for completion by July 17, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement through AmerisourceBergen's established...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Ibuprofen 800 mg tablets in quantities of 500 units, with a ceiling value of $1,160.93. This firm fixed-price delivery order is set to be completed by December 15, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a non-competitive, competitively awarded transaction under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,151.85 to AmerisourceBergen Drug Corp for the supply of Ibuprofen 800 mg tablets (500-count units). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded on January 2, 2026, with an ultimate completion date of January 5, 2026. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $2,984.70 firm fixed price delivery order to AmerisourceBergen Drug Corp for 500 tablets of Ibuprofen 800 mg, with a completion date of December 5, 2025. This non-set-aside contract was competitively awarded and represents a direct fulfillment order under AmerisourceBergen's existing federal pharmaceutical supply agreements. The contractor, headquartered in Conshohocken, Pennsylvania, will perform this delivery at its corporate office location. This...
- The Defense Logistics Agency awarded a $1,023.78 firm fixed price delivery order to AmerisourceBergen Drug Corp for 100 tablets of Ibuprofen 800 mg, with a completion date of December 31, 2025. This competitively awarded, non-set-aside contract represents a routine pharmaceutical procurement fulfilling medical supply requirements across federal healthcare systems. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor...
- The Defense Department's Medical Supply Chain awarded a $4,767.26 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the procurement of Ibuprofen 800 mg tablets (500-count units). This is a firm fixed price, competitively awarded contract with performance to be completed by July 21, 2025, and will be executed at the vendor's corporate office location in Conshohocken, Pennsylvania. No set-aside provisions were applied to this award. This delivery order is issued under...
- This is a $1,265.26 delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of ibuprofen 600 mg tablets in 100-count bottles, with a performance period ending on June 9, 2025. The contract is a firm fixed-price arrangement and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FA2Q2Delivery Order
The Defense Logistics Agency awarded a delivery order to Amerisourcebergen Drug Corp (parent company Cencora, Inc.) on January 15, 2026, for the supply of Ibuprofen 400 mg tablets in quantities of 500 units. This firm fixed-price delivery order carries a ceiling value of $1,124.96 and is scheduled for ultimate completion by January 16, 2026. The contract was awarded on a competitive, non-set-aside basis and will be performed at the contractor's Conshohocken, Pennsylvania location. This delivery order is issued under Amerisourcebergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to military healthcare programs worldwide. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and critical federal vendor with extensive experience fulfilling medical procurement requirements for military and veteran healthcare systems. The company's federal contract portfolio demonstrates consistent capability to deliver diverse pharmaceutical products across multiple therapeutic domains through competitive procurement processes. DLA Troop Support Medical is currently planning next-generation Pharmaceutical Prime Vendor Global Program contracts that may involve multiple regional awards, positioning Amerisourcebergen to continue supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 1/14/26 |